Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2987936 | Journal of Vascular Surgery | 2016 | 10 Pages |
Abstract
Xilonix was well tolerated. Observed tendency to improved vessel patency with intravenous dosing suggests Xilonix could potentially represent a safe and effective therapeutic approach to preserving vessel patency.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hosam MD, PhD, Richard MD, Michael MD, Prasant MBBS, Mark MD, PhD,